Pure Global

MAGLUMI DHEA-S - India CDSCO Medical Device Registration

MAGLUMI DHEA-S is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000060_f9492648c4750b5266491151fb689c16_a9e48509a5d77b4d0eccfa56efa25404. This device is marketed under the brand name CLIA. The license holder is M/s. Golden Harvest Industries, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
MAGLUMI DHEA-S
UID: IMP/IVD/2020/000060_f9492648c4750b5266491151fb689c16_a9e48509a5d77b4d0eccfa56efa25404

Brand Name

CLIA

Device Class

Class B

Approving Authority

CDSCO

Product Information

The kit is an in vitro chemiluminescence immunoassay for the quantitative determination of dehydroepiandrosterone (CLIA) in human serum using the MAGLUMI series Fully-auto chemiluminescence immunoassay analyzer (CLIA)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing